Literature DB >> 22949096

In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule.

Muhammad Irshad1, Wil A van der Reijden, Wim Crielaard, Marja L Laine.   

Abstract

Porphyromonas gingivalis is a Gram-negative, anaerobic bacterium involved in periodontitis and peri-implantitis that can invade and survive inside host cells in vitro. P. gingivalis can invade human gingival fibroblasts (GF), but no data are available about the role of P. gingivalis' capsule in GF invasion. In the current study, we aimed to determine the ability of three strains of P. gingivalis (encapsulated wild type W83, non-encapsulated HG91 and the non-encapsulated insertional isogenic knockout mutant of W83, ΔEpsC) to invade GF and the ability of internalized P. gingivalis to survive in vitro antibiotic treatment. The ability of P. gingivalis strains to invade GF was tested using an antibiotic protection assay at multiplicity of infection (MOI) 100 and 1000. The survival of internalized P. gingivalis cells was further analyzed by subsequent in vitro treatment with either metronidazole or amoxicillin alone or a combination of metronidazole and amoxicillin and anaerobic culture viability counts. All strains of P. gingivalis used in this study were able to invade GFs. The non-encapsulated mutant of W83 (ΔEpsC mutant) was significantly more invasive than the wild type W83 at MOI 100 (p value 0.025) and MOI 1000 (p value 0.038). Furthermore, internalized P. gingivalis was able to resist in vitro antibiotic treatment. As demonstrated by the differences in invasion efficiencies of P. gingivalis strain W83 and its isogenic mutant ΔEpsC, the capsule of P. gingivalis makes it less efficient in invading gingival fibroblasts. Moreover, internalized P. gingivalis can survive antibiotic treatment in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949096     DOI: 10.1007/s00005-012-0196-8

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  12 in total

1.  Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA.

Authors:  Young-Suk Choi; Ji-Hoi Moon; Tae-Geum Kim; Jin-Yong Lee
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  Deletion of a 77-base-pair inverted repeat element alters the synthesis of surface polysaccharides in Porphyromonas gingivalis.

Authors:  Brian W Bainbridge; Takanori Hirano; Nicole Grieshaber; Mary E Davey
Journal:  J Bacteriol       Date:  2015-01-26       Impact factor: 3.490

Review 3.  Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line.

Authors:  Kah Yan How; Keang Peng Song; Kok Gan Chan
Journal:  Front Microbiol       Date:  2016-02-09       Impact factor: 5.640

Review 4.  Oral Biofilms from Symbiotic to Pathogenic Interactions and Associated Disease -Connection of Periodontitis and Rheumatic Arthritis by Peptidylarginine Deiminase.

Authors:  Katja Kriebel; Cathleen Hieke; Brigitte Müller-Hilke; Masanobu Nakata; Bernd Kreikemeyer
Journal:  Front Microbiol       Date:  2018-01-30       Impact factor: 5.640

Review 5.  Molecular mechanisms of Porphyromonas gingivalis-host cell interaction on periodontal diseases.

Authors:  Masaaki Nakayama; Naoya Ohara
Journal:  Jpn Dent Sci Rev       Date:  2017-08-09

6.  Invasion of Porphyromonas gingivalis strains into vascular cells and tissue.

Authors:  Ingar Olsen; Ann Progulske-Fox
Journal:  J Oral Microbiol       Date:  2015-08-31       Impact factor: 5.474

7.  Porphyromonas gingivalis downregulates the immune response of fibroblasts.

Authors:  Eleonor Palm; Hazem Khalaf; Torbjörn Bengtsson
Journal:  BMC Microbiol       Date:  2013-07-10       Impact factor: 3.605

8.  Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production.

Authors:  Hong-Yan Wang; Li Lin; Wei Fu; Hui-Yuan Yu; Ning Yu; Li-Si Tan; Jya-Wei Cheng; Ya-Ping Pan
Journal:  BMC Complement Altern Med       Date:  2017-08-29       Impact factor: 3.659

9.  Evaluation of efficacy of probiotic (BIFILAC) on Porphyromonas gingivalis: In vitro study.

Authors:  Sugumari Elavarasu; Thangakumaran Suthanthiran; Arthiie Thangavelu; Shiva Shangkharii Kanagaraj; Lakshmi Mohandas; Santhosh Sekar
Journal:  J Pharm Bioallied Sci       Date:  2016-10

10.  Genes Contributing to Porphyromonas gingivalis Fitness in Abscess and Epithelial Cell Colonization Environments.

Authors:  Daniel P Miller; Justin A Hutcherson; Yan Wang; Zuzanna M Nowakowska; Jan Potempa; Deborah R Yoder-Himes; David A Scott; Marvin Whiteley; Richard J Lamont
Journal:  Front Cell Infect Microbiol       Date:  2017-08-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.